University of Texas at Austin School of Nursing
Austin, Texas, 78701, United States
NCT Number: NCT02918513
The purpose of this study is to explore the efficacy and feasibility of an integrated, prescriptive, and trackable wellness intervention combining five wellness elements including exercise, mindfulness, sleep, social connectedness, and nutrition.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Austin, Texas, 78701, United States
This study involves participating in a 90-day integrated, prescriptive, trackable wellness intervention, which includes five wellness elements: exercise, mindfulness, sleep, social connectedness, and nutrition.
The intervention is divided into three phases (each spanning 30-days): Phase 1 - 'Boot Camp', Phase 2 - Solidify, and Phase 3 - Sustain. Program requirements include: Implementing 5 wellness interventions daily for the first 30-days, at least 5 days for the next 30-days, and at least 3 days for the final 30-days, documenting daily online adherence, completing daily wellness exercises to improve mental wellness, and completing online program forms prior to beginning the program, at 30-days, and again at 90-days.
Once eligibility is confirmed via the initial orientation/screening call, study personnel will mail each participant a WILD 5 Wellness Workbook within one day of emailing participants their unique identification codes plus their start dates. Participants will be instructed to document adherence regarding their daily wellness practices and their daily wellness exercises online via Qualtrics, an online survey software. Participants can document their daily adherence using their computer and/or their smartphone as Qualtrics offers a mobile version of the Participant Tracking Form. A copy of the Participant Tracking Form will also be available in the WILD 5 Workbook so participants that prefer keeping a daily paper log can do so, and they can then transfer their program adherence information to the online Participant Tracking Form throughout the program. The workbook will contain the participant's personal identification code; no personal identification will appear in the workbook in order to protect participant confidentiality.
One day prior to a participant's start date, which will be set during the orientation/screening call, participants will receive an automated email from an online automated email service (MailChimp), with a reminder about their start date, and encouragement to contact study personnel with any questions or concerns.
Participants will also receive daily motivational emails from an online automated email service (MailChimp), which will provide general information about one of the five wellness elements and/or one of the wellness exercises, as well as encouragement to track their participation on a daily basis, and encouragement to contact study personnel via email with any questions and/or concerns.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 0, 30, and 90 days - Primary endpoint is 30 days
A self-reported depression scale used to assess severity of depression.
Time frame: 0, 30, and 90 days - Primary endpoint is 30 days
A self-reported questionnaire used to assess anxiety symptoms.
Time frame: 0, 30, and 90 days - Primary endpoint is 30 days
A brief scale that measures mental well- being.
Time frame: 0, 30, and 90 days - Primary endpoint is 30 days
A popular measure of mindfulness.
Time frame: 0, 30, and 90 days - Primary endpoint is 30 days
A brief scale that evaluates insomnia disorder.
Time frame: 0, 30, and 90 days - Primary endpoint is 30 days
A brief scale that assesses the degree to which respondents feel connected to others.
Time frame: 0, 30, and 90 days - Primary endpoint is 30 days
A scale assessing how individuals cope with and appraise stress in relation to food and eating.
Time frame: 0, 30, and 90 - Primary endpoint is 30 days
A combination of the Mediterranean and DASH (Dietary Approaches to Stop Hypertension) diets shown to lower a person's risk of developing Alzheimer's disease.
Time frame: 0, 30, and 90 days - Primary endpoint is 30 days
A measurement tool for assessing clinical pain.
Time frame: 0, 30, and 90 days - Primary endpoint is 30 days
A measurement tool for assessing functional impairment in three inter-related domains: work/school, social and family life.
Time frame: 0, 30, and 90 days - Primary endpoint is 30 days
A brief self-report questionnaire designed to obtain a sensitive measure of work productivity.
Time frame: 0, 30, and 90 days - Primary endpoint is 30 days
A brief scale that measures cognitive and executive dysfunction.
Time frame: 0, 30, and 90 days - Primary endpoint is 30 days
A brief scale designed specifically for this project to measure wellness.
Time frame: 0, 30, and 90 days - Primary endpoint is 30 days
A scale designed specifically for this project to measure weekly adherence with program elements.
Time frame: 0, 30, and 90 days - Primary endpoint is 30 days
A scale designed specifically for this project to measure elements of depression, anxiety, wellbeing, mindfulness, sleep quality, social connectedness, emotional eating, diet practices, pain, disability, work productivity, happiness, enthusiasm, resilience, and optimism.
Time frame: 90 days
A brief post study survey that captures participants' opinions about WILD 5 Wellness: 90-Day Intervention, and subjective ranking of their overall wellness.
University of Texas at Austin
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05451589
Anxiety, Anxiety Disorders
Ann Arbor, Michigan, United States
View Trial DetailsNCT03316846
Anxiety, Anxiety Disorders
Uppsala, Uppland, Sweden
View Trial DetailsNCT03993548
Arthritis, Arthritis, Rheumatoid
Austin, Texas, United States
View Trial DetailsNCT06689345
COVID-19, Chronic Disease
Sâo Bernardo Do Campo, São Paulo, Brazil
View Trial Details